APP and Alzheimer disease: Molecular, cellular, gene expression, and immunochemical studies of post-mortem human AD brains, brain samples from AD transgenic mice, platelets from AD patients, and cell lines expressing mutant APP and/or Aβ-treated cells (for ref, see [30]) have revealed multitarget dysfunction of the mitochondrial electron transfer chain (ETC) [25,28,30].